Description
Used in the treatment of:
- Metastatic colorectal cancer
- Non-Small Cell Lung Cancer (NSCLC)
- Glioblastoma
- Metastatic renal cell carcinoma
- Ovarian and cervical cancer
Bevacizumab is a recombinant humanized monoclonal antibody that inhibits vascular endothelial growth factor (VEGF), reducing tumor angiogenesis and slowing cancer growth.



